by charlebois | Apr 10, 2014 | Volume 62, Volume 62, Issue 1
Justin F. Marceau Volume 62, Issue 1, 1-66 Countless articles and judicial opinions have been devoted to the task of deciphering the scope and application of the limitations on habeas corpus relief announced in the Anti- Terrorism and Effective Death Penalty Act of...
by charlebois | Apr 10, 2014 | Volume 62, Volume 62, Issue 1
Patrick S. Shin Volume 62, Issue 1, 67-102 Recent scholarship in employment discrimination law has wrestled with the problem of unconscious bias and its implications for antidiscrimination law. This Article addresses what some might regard as a naïve question: Should...
by charlebois | Apr 10, 2014 | Volume 62, Volume 62, Issue 1
Scott E. Sundby Volume 62, Issue 1, 103-154, Using data from the Capital Jury Project, this Article takes a close look inside the jury room at the process by which capital juries reach a unanimous verdict at the penalty phase. The Article first examines the...
by charlebois | Apr 10, 2014 | Volume 62, Volume 62, Issue 1
Andrew Meade Volume 62, Issue 1, 155-184 The manner in which design defects should be defined has caused more controversy than any other area of products liability law. The Restatement (Third) defines a product design as defective when the foreseeable risks of harm...
by charlebois | Apr 10, 2014 | Volume 62, Volume 62, Issue 1
Ashley McHugh Volume 62, Issue 1, 185-220 Biotechnology companies and research institutions have patented thousands of genes based on the idea that a gene in an isolated and purified form is a patentable invention. The biotechnology industry has since grown to a...
